Bacterial vaginosis. Acute vaginitis
Conditions
Interventions
Intervention 1: Intervention 1, Tinidazole, oral tablet, 2 g daily for two day,brand name:Tindamax, Manufacturer:Kimidaru. Intervention 2: Intervention 2, Metronidazole, oral tablet, 500 mg, twice da
Treatment - Drugs
Intervention 1, Tinidazole, oral tablet, 2 g daily for two day,brand name:Tindamax, Manufacturer:Kimidaru
Intervention 2, Metronidazole, oral tablet, 500 mg, twice daily for seven day, brand name: Metromax , Manufacturer:kimidaru
Sponsors
Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Eligibility
Sex/Gender
Female
Age
15 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age 45-15 years, married women, diagnosis of bacterial vaginosis by clinical signs and diagnostic tests, accept the use of condoms during treatment. Exclusion criteria: associated with Candida vaginitis and trichomonas, Pregnancy, consume antibiotics at the same time or within two weeks and using the vaginal cream, metronidazole used simultaneously to any cause, having a chronic disease and diabetes, Immunosuppression or immune-lowering medication use, having cervicitis, chronic bacterial vaginosis
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vaginal discharge. Timepoint: Pre intervention, two and four weeks after treatment. Method of measurement: Observation.;Vaginal PH. Timepoint: Pre intervention.two and four weeks after treatment. Method of measurement: Universal indicator paper.;Wiff test. Timepoint: Pre intervention,two and four weeks after treatment. Method of measurement: KOH.;Clue cell. Timepoint: Pre intervention, two and four weeks after treatment. Method of measurement: Pap smear. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZeinab Rabee
Ahvaz Jundishapur University of Medical Sciences
Outcome results
None listed